196 related articles for article (PubMed ID: 31138789)
1. ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma.
Wu YJ; Ko BS; Liang SM; Lu YJ; Jan YJ; Jiang SS; Shyue SK; Chen L; Liou JY
Cell Death Dis; 2019 May; 10(6):408. PubMed ID: 31138789
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY
Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401
[TBL] [Abstract][Full Text] [Related]
3. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma.
Zhao Z; Hu Y; Shen X; Lao Y; Zhang L; Qiu X; Hu J; Gong P; Cui H; Lu S; Zheng Y; Zhou M; Fan H
Oncol Rep; 2017 May; 37(5):2811-2818. PubMed ID: 28339081
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression.
Chin HG; Ponnaluri VK; Zhang G; Estève PO; Schaus SE; Hansen U; Pradhan S
Oncotarget; 2016 Dec; 7(50):83627-83640. PubMed ID: 27845898
[TBL] [Abstract][Full Text] [Related]
5. The novel mTOR inhibitor Torin-2 induces autophagy and downregulates the expression of UHRF1 to suppress hepatocarcinoma cell growth.
Wang C; Wang X; Su Z; Fei H; Liu X; Pan Q
Oncol Rep; 2015 Oct; 34(4):1708-16. PubMed ID: 26239364
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
7. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.
Ma X; Guo P; Qiu Y; Mu K; Zhu L; Zhao W; Li T; Han L
Oncotarget; 2016 Jun; 7(24):36185-36197. PubMed ID: 27167192
[TBL] [Abstract][Full Text] [Related]
8. Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
Oncotarget; 2015 Nov; 6(36):38967-82. PubMed ID: 26516929
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
10. Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.
Butler JS; Qiu YH; Zhang N; Yoo SY; Coombes KR; Dent SY; Kornblau SM
Leuk Lymphoma; 2017 May; 58(5):1207-1218. PubMed ID: 28185526
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic Inhibition of the Menin-MLL Interaction Leads to Transcriptional Repression of
Kempinska K; Malik B; Borkin D; Klossowski S; Shukla S; Miao H; Wang J; Cierpicki T; Grembecka J
Mol Cancer Ther; 2018 Jan; 17(1):26-38. PubMed ID: 29142068
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic alterations contribute to promoter activity of imprinting gene IGF2.
Zheng QF; Xu B; Wang HM; Ding LH; Liu JY; Zhu LY; Qiu H; Zhang L; Ni GY; Ye J; Gao SB; Jin GH
Biochim Biophys Acta Gene Regul Mech; 2018 Feb; 1861(2):117-124. PubMed ID: 29413895
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
Li Y; Zhuang W; Huang M; Li X
Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade.
Datta J; Majumder S; Kutay H; Motiwala T; Frankel W; Costa R; Cha HC; MacDougald OA; Jacob ST; Ghoshal K
Cancer Res; 2007 Mar; 67(6):2736-46. PubMed ID: 17363595
[TBL] [Abstract][Full Text] [Related]
16. Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.
Bárcena-Varela M; Caruso S; Llerena S; Álvarez-Sola G; Uriarte I; Latasa MU; Urtasun R; Rebouissou S; Alvarez L; Jimenez M; Santamaría E; Rodriguez-Ortigosa C; Mazza G; Rombouts K; San José-Eneriz E; Rabal O; Agirre X; Iraburu M; Santos-Laso A; Banales JM; Zucman-Rossi J; Prósper F; Oyarzabal J; Berasain C; Ávila MA; Fernández-Barrena MG
Hepatology; 2019 Feb; 69(2):587-603. PubMed ID: 30014490
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
18. The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma.
Chen M; Fang Y; Liang M; Zhang N; Zhang X; Xu L; Ren X; Zhang Q; Zhou Y; Peng S; Yu J; Zeng J; Li X
J Transl Med; 2023 Apr; 21(1):276. PubMed ID: 37088830
[TBL] [Abstract][Full Text] [Related]
19. Fgfr3 is a transcriptional target of Ap2delta and Ash2l-containing histone methyltransferase complexes.
Tan CC; Walsh MJ; Gelb BD
PLoS One; 2009 Dec; 4(12):e8535. PubMed ID: 20046871
[TBL] [Abstract][Full Text] [Related]
20. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
